FdaApplication
NDA 010533
Identifiers
- fda_app_no: NDA010533
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PBZ-SR | TRIPELENNAMINE HYDROCHLORIDE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
| PBZ-SR | TRIPELENNAMINE HYDROCHLORIDE | 50MG | TABLET, EXTENDED RELEASE;ORAL |
2 products